Mesoblast Limited
Industry
- Pharmaceuticals
- Drug Delivery
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Gene Therapy, Cell Therapy
- Drug Discovery Technologies
Other Names/Subsidiaries
- Angioblast Systems Inc.
Latest on Mesoblast Limited
Equillium is hoping that unmet medical need and long-term efficacy will persuade the US Food and Drug Administration to approve itolizumab for acute graft-versus-host disease (aGVHD) despite its Phase
The US Food and Drug Administration maintained a high rate of complete response letter actions for novel agent applications in 2024, but recent history suggests that many of the 16 CRL recipients will
The median review times for US Food and Drug Administration-approved novel agents in 2024 held very close to Prescription Drug User Fee Act goals, highlighting the fundamental predictability of the re
China has granted its first regulatory approval for a stem cell therapy despite mixed results from the supporting Phase II clinical trial on which the marketing green light was based. On 2 January, th